Skip to content
ClinCalc Pro
Menu
Ocular lubricant (viscous eye drop — dry eye disease)

Sodium Hyaluronate 0.1% Eye Drops (Hylo-Forte)

Brand names: Hylo-Forte, Hylo-Tear, Artelac Rebalance, Clinitas

Sodium hyaluronate eye drops (e.g. Hylo-Forte) are a preservative-free ocular lubricant used to relieve symptoms of moderate to severe dry eye disease and ocular surface dryness.

Not a dosed medicine

Use as directed by the product's instructions, and check your local formulary.

Clinical monograph

How it works

The hyaluronate binds water and forms a long-lasting, stable lubricating film on the ocular surface, reducing friction and supporting corneal and conjunctival hydration.

Prescribing in practice

  • Although preservative-free and suitable for frequent use, advise patients to seek review if symptoms persist or worsen, as persistent dry eye may indicate an underlying ocular surface disorder requiring further assessment.
  • Can be used as often as required and is generally suitable for use with contact lenses, but confirm against the product information.
  • The multidose preservative-free bottle typically remains usable for an extended period after opening; check the labelled in-use shelf life.

Monitoring

No laboratory monitoring is needed; assess symptom relief and ocular surface condition at clinical review.

Counselling the patient

  • Expect brief blurring after each drop and wait for vision to clear before driving or operating machinery.
  • Store and use within the in-use period stated on the bottle and avoid touching the dropper tip to the eye or any surface.

Evidence & guidelines

Preservative-free lubricants are favoured for frequent or long-term dry eye treatment to avoid preservative-induced ocular surface toxicity, consistent with NICE dry eye guidance.

Reference: DEWS II Report 2017; NICE guidance Dry Eye; Hylo-Forte SPC; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.